Spots Global Cancer Trial Database for Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Official Title: Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Study ID: NCT01780701
Conditions
Study Description
Brief Summary: A prostate cancer diagnosis starts a list of events that often leads to fast-moving treatment, thought by many to result in vast over-treatment of this disease. So, discovery of different diagnostic methods that allow clinicians to identify slow-growing from potentially fast-growing disease prior to or at the time of prostate biopsy could result in early and suitable treatment for men at greatest risk, while greatly decreasing the number of biopsies, surgical procedures, hormonal and chemotherapeutic treatments, cost, and patient worry, for those with more slow-growing disease.
Detailed Description:
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Portland VA Medical Center, Portland, Oregon, United States
Oregon Health & Science University Advanced Imaging Research Center, Portland, Oregon, United States
Contact Details
Name: Jackilen Shannon, PhD
Affiliation: Oregon Health and Science University
Role: PRINCIPAL_INVESTIGATOR
Name: Jonathan Q Purnell, MD
Affiliation: Oregon Health and Science University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
